<DOC>
	<DOCNO>NCT02254057</DOCNO>
	<brief_summary>Study assess tolerability BIBT 986 BS intravenous infusion 0.1 , 0.3 , 1.0 , 2.5 , 5.0 , 10 mg , assess pharmacokinetics BIBT 986 BS intravenous infusion ass effect BIBT 986 BS blood coagulation parameter</brief_summary>
	<brief_title>Tolerability Pharmacokinetics/-Dynamics Single Rising Doses BIBT 986 BS Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male subject determine result screen Signed write informed consent accordance Good Clinical Practice ( GCP ) local legislation Age &gt; = 18 &lt; = 55 year BMI &gt; = 18.5 &lt; = 29.9 kg/m2 Any finding medical examination ( include blood pressure , pulse rate , electrocardiogram ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder Relevant history orthostatic hypotension , faint spell blackouts Any bleed disorder include prolonged habitual bleeding History hematologic disease , cerebral bleeding ( e.g . car accident ) , commotio cerebri Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Seasonal rhinitis Thrombocytes &lt; 150000/Î¼l Intake drug long halflife ( &gt; 24 hour ) ( &lt; 1 month prior administration trial ) Use drug , might influence result trial ( &lt; 10 day prior administration trial ) Participation another trial investigational drug ( &lt; 2 month prior administration trial ) Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Alcohol abuse ( &gt; 60 g/day ) Drug abuse Use methylxanthinecontaining drink food ( coffee , tea , cola , energy drink , chocolate , etc . ) , grapefruit grapefruit juice , alcohol , green tea , tobacco &lt; 5 day prior administration study drug trial Blood donation loss &gt; 400 ml , &lt; 1 month prior administration trial Excessive physical activity &lt; 5 day prior administration study drug trial Clinically relevant laboratory abnormality Any ECG value outside reference range clinical relevance include , limited QRS interval &gt; 110 m QTcB &gt; 450 m Inability comply dietary regimen study centre Inability comply investigator 's instruction</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>